Environmental

Very high R&D intensity versus peers supports a lower direct operating footprint, but it also indicates a resource-heavy development model typical of medtech innovators.

Low leverage relative to peers reduces balance-sheet pressure that can otherwise constrain environmental compliance spending, although it is not an environmental differentiator by itself.

Negative gross margin versus peers suggests a less efficient cost structure, which can indirectly limit capital available for environmental controls and process improvements.

No disclosed post-August 2025 environmental controversies were provided, so the assessment relies on capital-intensity and disclosure profile rather than verified emissions or resource-use data.

Social

High R&D spending versus peers can support product innovation and patient benefit, but it also increases dependence on specialized talent and execution discipline.

Stock-based compensation remains elevated versus peers, which can aid retention in a competitive labor market while also signaling heavier dilution pressure on employees and shareholders.

Negative gross margin versus peers may constrain investment in training, service quality, and customer support, which are important social factors in regulated medical devices.

No verified labor, product-safety, or community controversies were provided, leaving the social profile moderately positioned but not clearly advantaged versus peers.

Governance

Debt-to-equity is low versus peers, which reduces creditor oversight pressure, but it does not offset the governance concern from weak operating profitability.

Stock-based compensation at 26.6% of revenue is high versus peers, indicating a more dilutive pay structure that can weaken alignment if not tightly controlled.

Negative gross margin versus peers suggests limited operating discipline, which can heighten scrutiny of capital allocation and board oversight in a cash-intensive medtech model.

The absence of provided filing-based board, audit, or controversy data limits confidence, so governance is assessed as mixed rather than structurally weak versus peers.

Overall Score

NNOX appears moderately positioned versus peers overall, with high R&D commitment and low leverage offset by weak profitability and elevated stock-based compensation.

Score Driver: Weak Operating Profitability Relative To Peers